This is great news, obviously, however NEK1 gene has been previously described as possibly involved in ALS. More so, as mentioned in the article only 3% of patients carry the variation, meaning this is not and won't be a silver bullet for treating ALS. It provides us some insight in the disease, might allow for early diagnosis/treatment of some patients, but other disease targets are needed.
This is great news, obviously, however NEK1 gene has been previously described as possibly involved in ALS. More so, as mentioned in the article only 3% of patients carry the variation, meaning this is not and won't be a silver bullet for treating ALS. It provides us some insight in the disease, might allow for early diagnosis/treatment of some patients, but other disease targets are needed.